510(k) device
Valvuloplasty Balloon Catheter (ValvuloPro)
Dongguan TT Medical, Inc. · Balloon Aortic Valvuloplasty (OZT, Class II) · First FDA decision Mar 20, 2026, newest Mar 20, 2026Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
21
Naming "Valvuloplasty"
MAUDE reports
66
Brand "Valvuloplasty", since 2015
PubMed studies
5,820
Mentioning "Valvuloplasty"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Valvuloplasty Balloon Catheter (ValvuloPro)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260437 · Decided Mar 20, 2026 · 37 days after receipt
Device type: Balloon Aortic Valvuloplasty (OZT) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Valvuloplasty", any status and sponsor, newest update first.
- REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve FailureActive, not recruiting
The Leeds Teaching Hospitals NHS TrustAcademic, hospital or other
NCT06557798 · 550 participants (planned) · Start Feb 4, 2025 · Primary completion Dec 2027
Device: Any commercially available Edwards or Medtronic transcatheter aortic valve with the TAV-in-TAV (Redo TAVI) indication · For: Aortic Valve Stenosis
Sites: Aarhus, Denmark; Copenhagen, Denmark; Helsinki, Finland · 63 sites in all
20 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Valvuloplasty", and for the whole product code for context.
This brand
66 reports: 40 malfunction, 20 injury, 5 death
Whole product code OZT
356 reports: 223 malfunction, 102 injury, 27 death
Newest reports for this brand
Bard Peripheral Vascular, Inc.
2020394-2026-02952 · Received Oct 2, 2026 · Event dated Sep 11, 2026
Device type: Balloon Aortic Valvuloplasty (OZT)
Device problem as coded: Deflation Problem; Difficult to Remove
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Valvuloplasty"[tiab]. The summary above synthesizes these.
- Balloon aortic valvuloplasty.
Wang A, Harrison JK, Bashore TM · Prog Cardiovasc Dis · 1997Review
- Percutaneous balloon valvuloplasty.
Nishimura RA, Holmes DR, Reeder GS · Mayo Clin Proc · 1990Review
- Advances in the Treatment of Pulmonary Valve Stenosis.
Scansen BA · Vet Clin North Am Small Anim Pract · 2023Review
- Percutaneous Mitral Balloon Valvuloplasty: Worldwide Trends.
Palacios IF · J Am Heart Assoc · 2019Editorial, Comment
- Balloon valvuloplasty.
Bourdillon P, Dillon J, Brown S, et al. · Indiana Med · 1990
- Balloon Aortic Valvuloplasty in the Era of Transcatheter Valve Replacement.
Garcia S, Kereiakes DJ · J Soc Cardiovasc Angiogr Interv · 2023Editorial
- Ebstein's anomaly: contemporary management strategies.
Sainathan S, da Fonseca da Silva L, da Silva JP · J Thorac Dis · 2020Review
- Lithotripsy-Assisted Aortic Valvuloplasty During TAVR.
Sardella G, Salvi N, Bruno E, et al. · JACC Cardiovasc Interv · 2019Case Reports, Video-Audio Media
- Aortic Valvuloplasty or Rootplasty for Aortic Regurgitation.
ElZein C, Roberson D, Hammad N, et al. · Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu · 2018Review
- Impella CP-assisted balloon aortic valvuloplasty.
Megaly M, Jones P · J Cardiol Cases · 2016
- Beyond Technical Success of Fetal Aortic Valvuloplasty.
Freud LR · JACC Adv · 2024Editorial
Other devices of this type
Also filed under product code OZT.
- V8 Transluminal BAV CatheterIntervalve, Inc. · 510(k) 2015
- True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 510(k) 2017
- ValvuloPro Valvuloplasty Balloon CatheterDongguan TT Medical, Inc. · 510(k) 2024
- KardiaPSI Balloon CatheterIntervention Tech, Inc. · 510(k) 2026
- OutFlo Aortic Valve Dilatation Balloon CatheterDisa Medinotec · 510(k) 2025
- Inoue Balloon aToray Industries, Inc. · 510(k) 2022
- V8 Balloon Aortic Valvuloplasty CatheterIntervalve, Inc. · 510(k) 2015
- True Dilatation Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.